3.4 Antiepileptics Flashcards
absence seizures
ethosuximide first, then valrpoate and clonazepam
myclonic seizures
valproate and clonazepam
febriel seizures
diazepam
status epilepticus
lorazepam or diapepam, fosphenytoin or phenytoin, alt. phenoboarbital
simple partial siaures
phenytoin, carbamazepine, alt penobarbital, primidone,
complex partial seizures
phenytoin, carbamazepine, alt. Primidone
loldes nonsedative antiseizure drug
phenytoin
penytoin action
blocks Na channels in their inactivated state (prolonging it) and slows its rate of recovery, prevents seizure propagation
Na channel acts in
resting(channed doesn_t move - activation (M) gate closed, inactivate gate opnes) open/activated (activation gate opens, sodium moves), inactivated (after deopolarizaiton inactivation (H) gate closes and channel blocked)
phenytoin other mechanism
at very high concentrations, phenytoin can block voltage dependent Ca cannels and interfere with the release of excitatory neurotransmitters
phenytoin is not a
not a generalized CNS depressant however, produces some degree of drowsiness and lethargy without producing hypnosis
Phenytoin absorption
slow and veriable
Phenytoin kinetics
non-linear (follows zero order kinetic elimination) – disproportiate increases with every inc in dose
phenytoin half life
12 to 24hrs at therapuetic dose but then at high dose it will be 60 hrs
Phenytoin daility dose
daily dose can produce large increases in the plasma concentration resuling in toxicity —->NEEDS PLASMA MONITORING (therapeutic range is 10-20ug/mL)
Phenytoin and enzyme induction
inducers of CYP450 like most antiepileptics
Status epilepticus and Phenytoin
given in the IV form of fosphenytoin, a produrg bc it has better pharmacokinetic and toxicity profile
Dose related toxicity to Phenytoin
CNS depression (lethargy, fatigue, drowsiness, nystagmus, ataxia, diplopia), gingival hyperplacia (gum hypertrophy***very imp) – occurs in about 20% of all pts during chronic therapy due to altered collagen metabolism, can be minimized with good oral hygien (Ca blockers can also casue gingival hyperplasia), hirsutism, coarsing of facial features occur in young pts (unpleasant in women), acne, megaloblastic anemia (pehnytoing interferes with folate absorption and increases its excretion), Aplastic anemia (immune -mediated–check CBC –they are succeptible to infection), behaviour changes (confusion, hallucination, drowsiness), osteomalacia (phenytoin desensitized target tissues to Vit D and interferes with Ca metabolism), inhibition of ADH release and inhib of insulin release (hyperglycemia, glycosuria–>hypovelemia), in pregnancy (teratogenic effect) –fetal hydantoin syndrom) cleft lip, cleft palate, growth retardation, microcephaly (possibly due to an epoxide metabolite of phenytoin)
Phenytoin is an inducer so
it induces metabolism of other anti-epileptics, anticoagulatns, oral contraceptives (steroids), levodopa, Vit D,
Inhibition of the metabolism of Phenytoin
chloramphenicol, dicumarol, cimetidine, sulfonamides
therapeutic uses of phenytoin
generalized tonic-clonic seizures, partial seizures (both simple and complex), status epilepticus (IV fosphenytoin), trigeminal neuralgia (occasionally)
fosphenytoin
prodrug of phytoin, rapily converted to pheytoin in plasma, IV can be used as a substute for phenytoin
fosphenytoin compared with phenytoin
fosphenytoin allows more rapid loading, IM adminsitration and IV administration with minimal vascular erosion –Phenytoin sodium should never be give IM as it can cause tissue damage and necrosis. Fosphenytoin can be used to control seizures during neurosurgery and status epilepticus
carbamazepine
prolongs the inactivated Na channel (identical to phenytoin) and inhibits high freq repetitive firing in neurons
carbamazepine absorption
slow oral abs
carbamazepine metabolism
metabolized in liver by oxidation –epoxide derivative (active metaboliet leading ot toxicity)
carbamazepine inducer
enzyme inducer of CYP450–auto induction
carbamazepine t 1/2
10 to 20hrs, reduced with repeated used
adverse effects of carbamazepine
dialational hypnatremia (due to inc ADH secretion), exfoliative dermatitis (unique to carbamazepine), fetal malformations (teratogenic) cleft lip, palate, spinabifida (more classic)
therapuetic uses of carbamazepine
partial/generalized epilepsy, trigeminal neuralgia (neuropathic pain), maniac depressive psychosis (bipolar disorder)
carbamazepine contraindications
should not be sued for pts with absence seizures bc it amy cause an inc in seizures, the mechanisms underlying carbamazepine aggravation of absence seizures are uncertain but are thought to involve enhancement of neuronal activity withing thalamocortical circuity
Oxcarbazepine
is a prodrug whose actions are similar to those of carbamazepine, with improved toxicity profile. Oxc dos not produce the epoxide metabolite wich is largely responsible for the adverse effects of carbamazepine. Less potent inducer of hepatic microsomal enzymes than carbamazepine. antiseizure efficacy and is comparable with that of carbamazepine, phenytoin and valproic acid
disadvantage of oxcarbazepine
more reports of hyponatremia with oxcarbazepine, eps in pts at risk
Phenobarbital
has specific anticonvulsant action at low dose – GABA a facilitatory action, anti glutamate action (those medated by activation of AMPA rec), Ca entry reduction, at high dos also blocks Na conductance like phenytoin
phenobarbital kinetics
long half life, enzyme induction, increases porphyrin synthesis - contraindicated in porphyrias, tolerance and dependence